Contact us

Let’s get in touch!

Let’s get in touch!

Let’s get in touch!

Our friendly team would love to hear from you.

Our friendly team would love to hear from you.

500+

500+

500+

Patients Treated

Implemented our cutting-edge solutions in over 100 lending institutions worldwide.

Patients with both new and existing devices can be individualized to the optimal settings in a single visit.

1.7M+

1.7M+

1.7M+

Patients with CRT

Millions of patients have existing CRT devices, and could benefit from individualized programming.

4.5%

4.5%

4.5%

Avg. Improvement in Ejection Fraction

A study in Heart Rhythm (2022) showed a 4.5% (absolute) improvement in Ejection Fraction compared to default CRT.

$3-5K

$3-5K

$3-5K

Cost of Non-Response /
Patient / Year¹

Non-responders have $3-5K per year in excess healthcare costs compared to responders.

General Info

Our friendly team is here to help.

Phone

Reach out to us by phone.

Reach out to us by phone.

(952) 248-4484

*The Myochron product is currently under development and has not been approved by regulatory authorities such as the FDA or other equivalent bodies outside the US. It is not available for sale, distribution, or commercial use at this time. The information provided on this website is for informational purposes only and should not be construed as medical advice, diagnosis, or treatment. Please consult with a qualified healthcare professional for any medical concerns or questions.

Subscribe to be in touch with latest updates & news.

©Myochron 2024.

*The Myochron product is currently under development and has not been approved by regulatory authorities such as the FDA or other equivalent bodies outside the US. It is not available for sale, distribution, or commercial use at this time. The information provided on this website is for informational purposes only and should not be construed as medical advice, diagnosis, or treatment. Please consult with a qualified healthcare professional for any medical concerns or questions.

Subscribe to be in touch with latest updates & news.

©Myochron 2024.

*The Myochron product is currently under development and has not been approved by regulatory authorities such as the FDA or other equivalent bodies outside the US. It is not available for sale, distribution, or commercial use at this time. The information provided on this website is for informational purposes only and should not be construed as medical advice, diagnosis, or treatment. Please consult with a qualified healthcare professional for any medical concerns or questions.

Subscribe to be in touch with latest updates & news.

©Myochron 2024.

*The Myochron product is currently under development and has not been approved by regulatory authorities such as the FDA or other equivalent bodies outside the US. It is not available for sale, distribution, or commercial use at this time. The information provided on this website is for informational purposes only and should not be construed as medical advice, diagnosis, or treatment. Please consult with a qualified healthcare professional for any medical concerns or questions.

Subscribe to be in touch with latest updates & news.

©Myochron 2024.